Use of Biological Drugs for Psoriasis: A Drug-utilization Study Using Tuscan Administrative Databanks

被引：0
|
作者：
Giometto, S. [1 ]
Tillati, S. [1 ]
Baglietto, L. [1 ]
Bortoli, N. D. [2 ]
Mosca, M. [3 ]
Conte, M. [4 ]
Tuccori, M. [5 ,6 ]
Gini, R. [7 ]
Lucenteforte, E. [1 ]
机构：
[1] Univ Pisa, Unit Med Stat, Dept Clin & Expt Med, Pisa, Italy
[2] Univ Pisa, Unit Gastroenterol, Dept Clin & Expt Med, Pisa, Italy
[3] Univ Pisa, Unit Rheumatol, Dept Clin & Expt Med, Pisa, Italy
[4] Univ Paris Saclay, UVSQ, Inserm, Villejuif, France
[5] Univ Pisa, Unit Pharmacol & Pharmacovigilance, Dept Clin & Expt Med, Pisa, Italy
[6] Univ Hosp Pisa, Unit Adverse Drug React Monitoring, Pisa, Italy
[7] Tuscan Reg Healthcare Agcy, Unit Pharmacoepidemiol, Florence, Italy
来源：
DRUG SAFETY | 2022年 / 45卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R1 [预防医学、卫生学];
学科分类号：
1004 ; 120402 ;
摘要：
P051
引用
收藏
页码：1152 / 1153
页数：2
相关论文
共 50 条
  • [21] Use of nonsteroidal anti-inflammatory drugs during pregnancy; A nationwide drug utilization study
    Meaidi, A.
    Morch, L.
    Torp-Pedersen, C.
    Rom, A.
    EUROPEAN JOURNAL OF OBSTETRICS & GYNECOLOGY AND REPRODUCTIVE BIOLOGY, 2022, 270 : E101 - E101
  • [22] OFF-LABEL USE OF ANTIEPILEPTIC DRUGS AND ITS COSTS - A DRUG UTILIZATION STUDY IN PORTUGAL
    Afonso-Silva, M.
    Oliveira-Martins, S.
    Cabrita, J.
    VALUE IN HEALTH, 2012, 15 (07) : A546 - A547
  • [23] Use of antiseizure medications and safety of branded versus generic formulations: A comparative study on Tuscan administrative databases
    Giometto, Sabrina
    Baglietto, Laura
    Conte, Marco
    Vannacci, Alfredo
    Tuccori, Marco
    Mugelli, Alessandro
    Gini, Rosa
    Lucenteforte, Ersilia
    EPILEPSY & BEHAVIOR, 2021, 117
  • [24] Biological treatments for paediatric psoriasis : a retrospective observational study on biological drug survival in daily practice in childhood psoriasis
    Phan, C.
    Beauchet, A.
    Burztejn, A. -C.
    Severino-Freire, M.
    Barbarot, S.
    Girard, C.
    Lasek, A.
    Reguiai, Z.
    Hadj-Rabia, S.
    Abasq, C.
    Brenaut, E.
    Droitcourt, C.
    Perrussel, M.
    Mallet, S.
    Phan, A.
    Lacour, J. -P.
    Khemis, A.
    Bourrat, E.
    Chaby, G.
    Deborde, R.
    Plantin, P.
    Maruani, A.
    Piram, M.
    Maccari, F.
    Fougerousse, A. -C.
    Kupfer-Bessaguet, I.
    Balguerie, X.
    Barthelemy, H.
    Martin, L.
    Quiles-Tsimaratos, N.
    Mery-Brossard, L.
    Pallure, V.
    Lons-Danic, D.
    Bouilly-Auvray, D.
    Beylot-Barry, M.
    Puzenat, E.
    Aubin, F.
    Mahe, E.
    JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2019, 33 (10) : 1984 - 1992
  • [25] Biological Treatments for Pediatric Psoriasis: A Retrospective Observational Study on Biological Drug Survival in Daily Practice in Childhood Psoriasis
    不详
    INDIAN JOURNAL OF PAEDIATRIC DERMATOLOGY, 2019, 20 (04) : 318 - 319
  • [26] Trajectories of Adherence to Biologic Disease-Modifying Anti-Rheumatic Drugs in Tuscan Administrative Databases: The Pathfinder Study
    Convertino, Irma
    Giometto, Sabrina
    Gini, Rosa
    Cazzato, Massimiliano
    Fornili, Marco
    Valdiserra, Giulia
    Cappello, Emiliano
    Ferraro, Sara
    Bartolini, Claudia
    Paoletti, Olga
    Tillati, Silvia
    Baglietto, Laura
    Turchetti, Giuseppe
    Trieste, Leopoldo
    Lorenzoni, Valentina
    Blandizzi, Corrado
    Mosca, Marta
    Tuccori, Marco
    Lucenteforte, Ersilia
    JOURNAL OF CLINICAL MEDICINE, 2021, 10 (24)
  • [27] Editorial: Biologic drugs in immune-mediated inflammatory diseases, validation, drug-utilization, effectiveness, regulation, costs, and safety in the real-world
    Convertino, Irma
    Lopes, Luciane Cruz
    Pratt, Nicole
    Ingrasciotta, Ylenia
    Tuccori, Marco
    FRONTIERS IN PHARMACOLOGY, 2025, 15
  • [28] Non-aspirin non-steroidal anti-inflammatory drug use in the Nordic countries 2000-2016 from a cardiovascular risk perspective: A drug-utilization study
    Kristensen, Kasper Bruun
    Karlstad, Oystein
    Martikainen, Jaana E.
    Pottegard, Anton
    Wastesson, Jonas W.
    Zoega, Helga
    Schmidt, Morten
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2019, 28 : 144 - 145
  • [29] Assessing disease activity of rheumatoid arthritis patients and drug-utilization patterns of biologic disease-modifying antirheumatic drugs in the Tuscany region, Italy
    Convertino, Irma
    Cazzato, Massimiliano
    Tillati, Silvia
    Giometto, Sabrina
    Gini, Rosa
    Valdiserra, Giulia
    Cappello, Emiliano
    Ferraro, Sara
    Bonaso, Marco
    Bartolini, Claudia
    Paoletti, Olga
    Lorenzoni, Valentina
    Trieste, Leopoldo
    Filippi, Matteo
    Turchetti, Giuseppe
    Cristofano, Michele
    Blandizzi, Corrado
    Mosca, Marta
    Lucenteforte, Ersilia
    Tuccori, Marco
    FRONTIERS IN PHARMACOLOGY, 2023, 14
  • [30] Rituximab off-label use for immune diseases: assessing adverse events in a single-centre drug-utilization survey
    Sailler, Laurent
    Attane, Camille
    Michenot, Fleur
    Canonge, Jean-Marie
    Rostaing, Lionel
    Arlet-Suau, Elizabeth
    Arlet, Philippe
    Launay, Francois
    Montastruc, Jean-Louis
    Lapeyre-Mestre, Maryse
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2008, 66 (02) : 320 - 322
12345